Business & Tech

Prominent Pharmacy Closing 3 More Connecticut Locations: Here's Where

Three Connecticut Walgreens are slated to close this month, followed by three more in May.

Three more Connecticut Walgreens stores have been added to the corporate chopping block.
Three more Connecticut Walgreens stores have been added to the corporate chopping block. (Chris Dehnel/Patch )

CONNECTICUT — Three more Connecticut Walgreens stores have been added to the corporate chopping block. They are slated to close in May, following three on the closure list for this month.

The latest to be shuttered are:

  • The Walgreens in East Hartford at 922 Silver Lane is slated to close on May 20. Customers will have an option of using the Walgreens at 20 Connecticut Boulevard.
  • The Walgreens at 1350 Stanley Street in New Britain is scheduled to close on May 19. A store at 102 Washington St. will remain.
  • In East Haven, the store at 157 Main Street is slated for a May 22 closure. The closest store would be in Branford, a store staffer said.

This month's closures, as previously announced, include:

Find out what's happening in Across Connecticutfor free with the latest updates from Patch.

  • Middletown at 311 East Main St. (April 23)
  • Waterbury at 11 Meriden Road (April 22)
  • Milford at 1083 Boston Post Road (April 21)

The rash of closings come in the wake of the Illinois-based Walgreens Boots Alliance third-quarter earnings report. In that report, Walgreens executives said the company is "launching a U.S. retail pharmacy action plan to invest in and deliver an improved customer and patient experience across channels" while "simplifying and focusing the U.S. Healthcare portfolio."

According to the earnings report, companywide sales increased 2.6 percent from the year-ago quarter to $36.4 billion, an increase of 2.5 percent on a constant currency basis, "reflecting sales growth across all segments."

Find out what's happening in Across Connecticutfor free with the latest updates from Patch.

The company also lowered its fiscal 2024 adjusted earnings per share guidance to $2.80 to $2.95 to reflect "challenging pharmacy industry trends and a worse-than-expected U.S. consumer environment."

Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.